StockData
Orthofix Medical Inc. logo

Orthofix Medical Inc. (OFIX) stock

OFIXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 23
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$6.67−0.13 (-1.91%)

Close on Nov 17, 2026Market cap $271.69MP/E –Yield –

Orthofix Medical revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Orthofix Medical's revenue for the twelve months ending Jun 30, 2026 was $833.19M, up 3.0% year over year. For fiscal 2025 it was $822.31M, up 2.9% from the year before. Over ten years it grew 7.6% a year on average. The highest annual figure on record is $822.31M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$822.31M+2.9%
FY2024Dec 31, 2024$799.49M+7.1%
FY2023Dec 31, 2023$746.64M+62.1%
FY2022Dec 31, 2022$460.71M-0.8%
FY2021Dec 31, 2021$464.48M+14.2%
FY2020Dec 31, 2020$406.56M-11.6%
FY2019Dec 31, 2019$459.96M+1.5%
FY2018Dec 31, 2018$453.04M+4.4%
FY2017Dec 31, 2017$433.82M+5.9%
FY2016Dec 31, 2016$409.79M+3.4%
FY2015Dec 31, 2015$396.49M-1.4%
FY2014Dec 31, 2014$402.28M+1.2%
FY2013Dec 31, 2013$397.61M-9.7%
FY2012Dec 31, 2012$440.19M+1.1%
FY2011Dec 31, 2011$435.52M-5.8%
FY2010Dec 31, 2010$462.57M-15.2%
FY2009Dec 31, 2009$545.64M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$210.93M+3.8%
Q1 FY2026Mar 31, 2026$196.71M+1.6%
Q4 FY2025Dec 31, 2025$219.91M+2.0%
Q3 FY2025Sep 30, 2025$205.63M+4.6%
Q2 FY2025Jun 30, 2025$203.12M+2.3%
Q1 FY2025Mar 31, 2025$193.65M+2.7%
Q4 FY2024Dec 31, 2024$215.66M+7.6%
Q3 FY2024Sep 30, 2024$196.61M+6.8%
Q2 FY2024Jun 30, 2024$198.62M+6.2%
Q1 FY2024Mar 31, 2024$188.61M+7.7%
Q4 FY2023Dec 31, 2023$200.42M+64.0%
Q3 FY2023Sep 30, 2023$184.01M+61.4%
Q2 FY2023Jun 30, 2023$187.02M+58.4%
Q1 FY2023Mar 31, 2023$175.20M+64.6%
Q4 FY2022Dec 31, 2022$122.23M-2.3%
Q3 FY2022Sep 30, 2022$114.00M+1.4%
Q2 FY2022Jun 30, 2022$118.07M-2.7%
Q1 FY2022Mar 31, 2022$106.42M+0.8%
Q4 FY2021Dec 31, 2021$125.06M+6.3%
Q3 FY2021Sep 30, 2021$112.43M+1.3%
Q2 FY2021Jun 30, 2021$121.39M+66.0%
Q1 FY2021Mar 31, 2021$105.59M+0.7%
Q4 FY2020Dec 31, 2020$117.62M-3.2%
Q3 FY2020Sep 30, 2020$110.99M-2.2%
Q2 FY2020Jun 30, 2020$73.14M-36.9%
Q1 FY2020Mar 31, 2020$104.82M-3.9%
Q4 FY2019Dec 31, 2019$121.49M+0.3%
Q3 FY2019Sep 30, 2019$113.50M+1.6%
Q2 FY2019Jun 30, 2019$115.85M+3.9%
Q1 FY2019Mar 31, 2019$109.11M+0.4%
Q4 FY2018Dec 31, 2018$121.08M+3.6%
Q3 FY2018Sep 30, 2018$111.71M+6.1%
Q2 FY2018Jun 30, 2018$111.55M+2.4%
Q1 FY2018Mar 31, 2018$108.71M+5.8%
Q4 FY2017Dec 31, 2017$116.90M+7.7%
Q3 FY2017Sep 30, 2017$105.25M+6.9%
Q2 FY2017Jun 30, 2017$108.94M–
Q1 FY2017Mar 31, 2017$102.74M–
Q4 FY2016Dec 31, 2016$108.54M–
Q3 FY2016Sep 30, 2016$98.50M–

More Orthofix Medical figures

See a number that looks wrong?